Internal Medicine 1017 - Internal Medicine Alert - Sep 15, 2006

Target Audience:

This activity is intended for the internist and family practitioner.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Joseph E. Scherger, MD, MPH
University of California, San Diego

Allan J. Wilke, MD
Residency Program Director
Associate Professor of Family Medicine
University of Alabama
Birmingham School of Medicine
Huntsville Regional Medical Campus

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Ralph R. Hall, MD, FACP
Emeritus Professor of Medicine
University of Missouri
Kansas City School of Medicine

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida

Ken Grauer, MD
Assistant Director
Family Practice Residency Program
University of Florida


  • Low-Dose Corticosteroid Use Safe in Rheumatoid Arthritis
  • Subclinical Hypothyroidism: To Treat or Not to Treat?
  • How Long is Long Enough?
  • OTC Sunscreen Cream (Anthelios SX Cream)
  • Clinical Briefs By Louis Kuritzky, MD
  • ECG Review: Just Before the Run


  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert's Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, and associate editors Joseph E. Scherger, MD, MPH, Allan J. Wilke, MD, James Chan, PharmD, PhD, William T. Elliott, MD, FACP, and Ken Grauer, MD report no financial relationships to this field of study. Associate editor Ralph R. Hall, MD, FACP is a consultant for Aventis. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.